Please provide your email address to receive an email when new articles are posted on . Vericel announced FDA approval of its arthroscopically administered biologic cartilage repair product. MACI ...
CEO Nick Colangelo highlighted the company's solid start to 2025, with record first-quarter MACI revenue exceeding $46 million and total company revenue of $52.6 million. He emphasized the strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback